Indian Liraglutide Exporters: Complete Supplier Ranking with Market Share — 53 Manufacturers (2026) — TransData Nexus

Q: Who is the largest liraglutide supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the largest liraglutide exporter from India with a 52.6% market share and export value of $2.3M.

Q: How many liraglutide suppliers are there in India?

There are 53 active liraglutide exporters in India, collectively shipping $4.3M worth of liraglutide across 416 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top liraglutide suppliers from India?

The top 5 liraglutide suppliers from India — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, LUPIN LIMITED, ABBOTT INDIA LIMITED, ONESOURCE SPECIALTY PHARMA LIMITED — together control 98.1% of total liraglutide export value from India.

Suresh Sormare

Liraglutide

India Pharmaceutical Trade Intelligence

$4.3M53 Suppliers36 CountriesHS 30049099

ExportsIndia → BELGIUM52.7%India → SOUTH AFRICA32.6%

ImportsDENMARK → India$157.8M GREECE → India$1.4M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Liraglutide Suppliers from India (2026) — 53 Exporters, $4.3M Market | TransData Nexus | TransData Nexus

Who Exports Liraglutide from India — 53 Suppliers Behind a $4.3M Market

India's liraglutide export market is supplied by 53 active exporters who collectively shipped $4.3M across 416 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 52.6% market share, followed by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI and LUPIN LIMITED. The top 5 suppliers together control 98.1% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Liraglutide Suppliers & Exporters — 53 manufacturers, $4.3M export market, top destinations and formulations — Liraglutide supplier data — 53 exporters · $4.3M market · 416 shipmentsTransData Nexus · Indian Customs Data

Top Liraglutide Exporters from India — Ranked by Export Value

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading liraglutide exporter from India, holding a 52.6% share of the $4.3M market across 416 shipments from 53 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, LUPIN LIMITED, ABBOTT INDIA LIMITED, ONESOURCE SPECIALTY PHARMA LIMITED — collectively control 98.1% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (52.6%), ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI (43.9%), LUPIN LIMITED (0.8%), ABBOTT INDIA LIMITED (0.5%), ONESOURCE SPECIALTY PHARMA LIMITED (0.3%).

Top Liraglutide Exporters from India

Ranked by export value · 53 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Liraglutide Exporters from India — Ranked by Export Value. 53 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Liraglutide exporters

Certification and compliance status for top Liraglutide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Sun Pharmaceutical Industries Limited	Warning Letter issued in	Yes, as of September	Yes	Not verified	Received FDA Warning Letter for CGMP violations at Dadra facility in June 2024.
Lupin Limited	Approved	Yes	Yes	Multiple	Received FDA approval for Travoprost Ophthalmic Solution in May 2024.
Abbott India Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.
Orbicular Pharmaceutical Technologies Private Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.
Onesource Specialty Pharma Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.
Regalia Life Science Private Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.
Viotonic Medication	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.
Movid Impex	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.
Rutva Medicare	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and maintains WHO-GMP and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 9 leading Liraglutide exporters from India. 8 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Liraglutide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for pharmaceutical manufacturing and research. The city contributes approximately 40% of India's bulk drug production and houses over 2,000 pharmaceutical companies. Notably, Hyderabad is home to major firms such as Aurobindo Pharma, Bharat Biotech, and Dr. Reddy’s Laboratories. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a leader in life sciences innovation.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region hosts prominent companies like Alembic Pharmaceuticals, Sun Pharma, and Cadila Pharmaceuticals. Vadodara, in particular, has evolved into a significant pharmaceutical hub, housing numerous large-scale industries and contributing substantially to the state's economy.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial gateway for pharmaceutical exports, leveraging its strategic coastal location and well-established port infrastructure. This region is home to several leading pharmaceutical companies, including Sun Pharmaceutical Industries Limited, which is the top exporter of Liraglutide, accounting for 52.6% of the total exports. The proximity to major ports facilitates efficient international distribution, making it a vital node in India's pharmaceutical supply chain.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Liraglutide exporters from India

January 2023

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Concert Pharmaceuticals for $576 million

Sun Pharma completed the acquisition of Concert Pharmaceuticals, a late-stage biotechnology company, enhancing its specialty and innovative product portfolio. IMPACT: This acquisition is expected to bolster Sun Pharma's capabilities in specialty pharmaceuticals, potentially influencing its Liraglutide export strategies.

Impact: This acquisition is expected to bolster Sun Pharma's capabilities in specialty pharmaceuticals, potentially influencing its Liraglutide export strategies.

March 2023

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires 60% stake in Vivaldis Animal Health

Sun Pharma acquired a majority stake in Vivaldis Animal Health and Foods, expanding its presence in the animal healthcare segment. IMPACT: While primarily focused on animal health, this diversification may indirectly affect Sun Pharma's resource allocation for Liraglutide exports.

Impact: While primarily focused on animal health, this diversification may indirectly affect Sun Pharma's resource allocation for Liraglutide exports.

Common Questions — Liraglutide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which liraglutide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 15 recorded shipments worth $2.3M. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI (91 shipments) and LUPIN LIMITED (10 shipments) are also established high-volume exporters.

Q How many liraglutide manufacturers are there in India?

India has 53 active liraglutide exporters with a combined export market of $4.3M across 416 shipments to 36 countries. The top 5 suppliers hold 98.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for liraglutide from India?

Average FOB unit price: $35.91 per unit, ranging from $0.00 to $1000.00. Average shipment value: $10.3K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Liraglutide

Liraglutide

Who Exports Liraglutide from India — 53 Suppliers Behind a $4.3M Market

Top Liraglutide Exporters from India — Ranked by Export Value

Top Liraglutide Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Concert Pharmaceuticals for $576 million

Sun Pharmaceutical Industries Limited — Sun Pharma acquires 60% stake in Vivaldis Animal Health

Common Questions — Liraglutide Suppliers from India

Q Which liraglutide supplier from India is the most reliable for bulk orders?

Q How many liraglutide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for liraglutide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — Sun Pharma partners with Pharmazz for ischemic stroke drug in India

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Analysis Methodology